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Abstract
Background: Benign fibrous histiocytomas (BFH) usually presents as a small benign lesion that
predominantly occurs in the skin. Only few cases of BFH arising from bone have been reported, its
occurrence in pelvic bones is even rarer.
Case presentation: A 34-year-old female presented with BFH at a rare anatomical location on
both sides of the os ilium which was larger than earlier reported BFH of the bone. Surgical resection
was performed successfully including resection of the inner pelvic ring and reconstruction of the
linea terminalis using a non-vascularized fibular autograft. At 18 months after tumor resection and
reconstruction of the pelvic ring, with interposition of a free vascularized fibula graft patient has an
excellent clinical oncological and functional outcome.
Conclusion: Non vascularized fibular autograft is a useful reconstructive procedure in select
patients.
Background
Benign fibrous histiocytoma (BFH) is a tumor that occurs
predominantly in the skin (also called dermatofibroma)
and most commonly in younger individuals. The tumor
typically presents as a painless nodule varying in size from
a few millimeters to several centimeters.
BFH of the bone has been a subject of increasing interest
within the past few years. The term was initially intro-
duced by Dominok in 1980 to describe a cystic lesion in
the femur of a 66-year-old man [1]. Only a few cases of
BFH of bone have been described in the literature since
then, and even fewer located in the pelvis [2-6].
Histologically, BFH arising from soft tissues cannot be dis-
tinguished from those arising from bone [7]. Pain is most
often the predominant presenting symptom [7], which
helps to distinguish this tumor clinically from other
fibrous lesions, such as non-ossifying fibroma. Peak inci-
dence of BFH arising from bone is reported in the third
decade [5].
On radiography the lesion is characterized by osteolytic
lesions with a well defined sclerotic margin [6]. Magnetic
resonance (MR) Imaging of BFH usually shows low signal
intensity on T1- and high signal intensity on T2-weighted
images. Peripheral contrast enhancement has also been
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described in BFH [4,8,9]. Computed tomographic (CT)
scan typically show fibrous osteolytic lesions with cortical
thinning [10]. Positive bone scans may be helpful in dif-
ferentiate BFH from nonossifying fibroma [4]. Biopsy is
mandatory to confirm the diagnosis: Histologically BFH
represents a benign but diverse group of neoplasms that
are characterized by both fibroblastic and histiocytic dif-
ferentiation. Giant cells of the "Touton" type and a "stori-
form pattern" are typically seen [11]. BFH shows
proliferation of benign oval or spindle cells resembling
fibroblasts mingled with cells resembling histiocytes.
Foam cells are a prominent component of the macroscop-
ically yellow zones of the tumor. It may be difficult to dif-
ferentiate BFH from low-grade malignant fibrous
histiocytoma. Lack of marked pleomorphism or of atypi-
cal mitoses is suggestive of a benign diagnosis. On micro-
scopic examination some forms of BFH show features of
dysplasia, such as hypercellularity, mitotic activity or focal
necrosis [2]. These entities are considered to be more
aggressive types of BFH, that should be treated with wide
surgical excision [2]; for non-aggressive types of BFH even
intralesional resection can be effective [7].
A local recurrence rate of 5 to 25 % is reported in litera-
ture. The recurrence rate is typically related to the size of
the tumor [2,12]. Consequently, careful clinical and radi-
ological follow-up including regular MRI is recom-
mended [2]. We present here a case of BFH treated with
resection and reconstructed using non vascularized fibu-
lar bone graft.
Case presentation
A 34-year-old female presented with a 3 year history of a
palpable swelling and mild pain in the left gluteal region.
There was no history of preceding trauma or accident. Two
years after initiation of symptoms without clinical
progress, the patient became pregnant and noted a local
growth of the mass. After giving birth to a healthy child,
the patient consulted an orthopedic surgeon. A radio-
graphic image of the pelvis revealed a large osteolytic
lesion in the left iliac wing, sharply contoured with scle-
rotic margins, indicating a slow growth pattern (Figure 1).
MR-imaging of the pelvis showed a mass originating from
the os ilium with a large extra- and intrapelvic soft-tissue
component (Figure 2). Open biopsy was performed that
lead to the diagnosis of BFH.
After reference to the literature on BFH, surgical en bloc
resection was considered to be the appropriate treatment
modality [2,3,12,13]. In accordance to the imaging
results, the iliac crest could be preserved, while the linea
terminalis of the left side had to be resected (Figure 3).
Figure 4 shows the resected tumor specimen. Histological
study of the resected specimen confirmed the diagnosis of
BFH (Figure 5). The surgical margins were found to be free
of tumor confirming complete tumor resection.
The pelvic ring was then stabilized in a second operation
using a non-vascularized fibular autograft that was
impacted and stabilized with screws and a Kirschner-wire
reconstructing the linea terminalis of the left pelvic ring
(Figure 6). Post operatively she developed neurapraxia of
the left lateral femoral cutaneous nerve, which resolved
spontaneously within 6 months after surgery. Following
two weeks of bed rest and limited restriction of movement
up to 70° flexion of the hip joint, the patient was mobi-
lized with partial weight bearing for three months.
Radiographic and MRI controls at 3, 6 and 12 months
postoperatively showed no evidence of local recurrence or
secondary dislocation of the reconstruction (Figure 7). A
diastasis of the symphysis was noted, which we ascribe to
the pregnancy one year prior to surgery. After 18 months
of surgery the patient is free of disease and ambulates with
full weight bearing.
Discussion
A rare anatomical location of BFH accompanied by an
extraordinary tumor size of 9.5 × 7 × 11 cm is presented in
this report. To our knowledge, no BFH of the bone with a
similar size has been published. Due to its size and loca-
tion on both sides of the iliac wing, including a large
Radiograph of the pelvis showing a well-circumscribed osteo- lytic lesion in the left iliac bone; it is sharply marginated with  a thin sclerotic rim and without any matrix calcifications Figure 1
Radiograph of the pelvis showing a well-circumscribed osteo-
lytic lesion in the left iliac bone; it is sharply marginated with 
a thin sclerotic rim and without any matrix calcifications.World Journal of Surgical Oncology 2004, 2:38 http://www.wjso.com/content/2/1/38
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osteolytic lesion of the os ilium, this tumor presented a
challenge for surgical resection.
There are only a few studies addressing the stability of the
pelvic ring following partial hemipelvectomy [14-17]. A
variety of problems, such as persistent instability and
complications caused by postoperative infections and
transplant dislocation, have been reported [14-17]. The
majority of the reconstructions reported have followed
extensive resection of malignant bone tumors. Allograft
[18], non-vascularized and vascularized auto grafts (fib-
ula, tibia, and femur) [15,19,20], endoprosthetic replace-
ment and other osteosynthetic procedures (i.e. with
Kuntscher rods and K-wires or transpedicular and iliac
screw systems) [14] have been used with differing degrees
of success and variable clinical outcome. After total sacrec-
tomy adequate reconstruction was reported in one study
to have been achieved with transpedicular and iliac screw
systems [21]. However K-wires were found to be insuffi-
cient for reconstruction of the ilium [14]. Within recent
years, the use of biological transplants for such reconstruc-
tions has been reported in a number of cases with func-
tionally satisfactory results [18,15,19,20].
In our case, we decided to reconstruct the inferior pelvic
ring with an impacted non-vascularized fibular autograft
to provide stability to the pelvic ring. No data is available
on the necessity for reconstructing the linea terminalis
when the continuity of the pelvic ring remains intact (a
bony bridge between sacrum and ilium was left intact in
a-d: MRI shows a mass originating from the ileum and extending into the soft tissues both anteromedially and posterolaterally Figure 2
a-d: MRI shows a mass originating from the ileum and extending into the soft tissues both anteromedially and posterolaterally. 
In T1-weighted sequences the mass is isointense with muscle (a). It enhances after administration of gadolinium (b, c). In fat-
suppressed T2-weighted sequences it has high signal intensity (d).World Journal of Surgical Oncology 2004, 2:38 http://www.wjso.com/content/2/1/38
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our case). We are of the opinion that stabilization of the
inner pelvic ring is necessary to prevent stress fracture of
the remaining bone bridge.
After mobilization of the patient an increasing diastasis of
the symphysis was noted (Figure 7). This might have been
caused by moderate shortening of the implanted fibular
graft, which can in turn result in rotation and tilting of the
affected hemipelvis. In our case loosening of the symphy-
sis following pregnancy and vaginal delivery prior to sur-
gery too might have contributed to diastasis in our case.
Oncologically the marginal tumor resection has proved to
be an adequate treatment. Despite high recurrence rates,
especially in the case of large BFH [2], no local recurrence
has so far been observed in our case. With a follow-up of
18 months after tumor resection as well as reconstruction
of the pelvic ring it seems to become a successfully per-
formed treatment for this patient.
Defect after tumor resection, with disruption of the linea  terminalis Figure 3
Defect after tumor resection, with disruption of the linea 
terminalis.
Macroscopic view of the resection specimen in transverse  orientation Figure 4
Macroscopic view of the resection specimen in transverse 
orientation. Large yellow osteodestructive tumor originating 
from iliac bone and with extensive extraosseous parts. Inva-
sion of massa lateralis of sacral bone. Sharp borders between 
tumor and bone are indicative of a slow-growing neoplasm.
Histology of the resection specimen Figure 5
Histology of the resection specimen. Spindle tumor cells 
admixed with some multinucleated giant cells (left) and 
foamy macrophages (middle) and cholesterol clefts (right). 
(Hematoxyllin and Eosin x)World Journal of Surgical Oncology 2004, 2:38 http://www.wjso.com/content/2/1/38
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